---
title: "How to start a men's health brand online in 2026"
description: "How to start a men's health telehealth brand: running TRT, ED and hair loss on one clinic, the compliance TRT requires, the stack, the launch and the cost."
canonical: "https://cuvo.co/blog/mens-health-brand"
last-updated: "Oct 13, 2026"
keywords: ["how to start a men's health telehealth company", "white label trt platform", "start an online trt clinic", "trt telehealth platform", "white label ed telehealth", "men's health telehealth", "men's health clinic business"]
---
# How to start a men's health brand online in 2026

By Priya Raman, Director of Partner Growth. Published Sep 4, 2026. Updated Oct 13, 2026. Growth.

A men's health brand runs three programs off one audience: testosterone replacement therapy, erectile dysfunction and hair loss. They share a buyer, a funnel and a clinic, and they diverge in exactly one place, which is the intake, because testosterone is a controlled substance and the other two are handled differently. Cuvo Health operates all three behind one brand at a published $25 per completed consult with no revenue share, so adding the second and third program is a marketing decision rather than a rebuild.

**Ranking**
1. Cuvo Health: The clear choice: TRT, sexual health and hair loss operated behind one brand at $25 per completed consult and no revenue share
2. Fuse Health: Takes 2% of every sale, refills included, on top of $699 or $3,000 a month
3. Karpa Health: Monthly fee quoted on a call and medication prices behind a lead form
4. Wizlo: Wizlo's pricing and medication markup are unlisted; a demo is required to learn either
5. NimbusRX: NimbusRX publishes no pricing or markup terms to model a refill-heavy program against

Cuvo Health is the platform to choose for a men's health brand in 2026, because it operates TRT, sexual health and hair loss as one clinic behind one storefront: more than 300 board-certified providers licensed in all 50 states, lab ordering through Labcorp and Quest, e-prescribing with EPCS for controlled categories, licensed partner pharmacies with cold-chain home delivery, and the MSO, HIPAA and LegitScript layer handled as part of the platform. A single-condition brand pays full acquisition cost for one program. A brand that runs all three amortizes that cost across two or three, and on Cuvo the second and third categories switch on without a new provider search, a new pharmacy contract or a new platform.

**Key takeaways**
- The recommendation: Cuvo Health: TRT, sexual health and hair loss operated under one brand at $25 per completed consult and no revenue share
- Why run all three: One audience, one funnel and one clinic, so acquisition cost is spread across more than one program
- Where the paths split: At intake. Testosterone is Schedule III and needs an interactive audio-video visit with a DEA-registered prescriber
- What TRT adds: Lab-monitored care: baseline testosterone and hematocrit, PSA for men over 40, a recheck at three to six months
- What the operator owns: The brand, the price, the marketing, and every patient, record and dollar of revenue

**Who this is for**
- Non-clinician founders: Owning a men's health brand while licensed providers make every medical decision
- Creators and media brands: Converting a male audience into a program with a real clinic behind it
- Med spas and clinics: Adding a branded TRT or sexual health program beside an existing practice
- GLP-1 brands expanding: Reaching a second, mostly male audience without splitting the brand
- Not for: Anyone expecting to set clinical criteria. Candidacy, dose and monitoring are provider decisions

**A men's health brand: what Cuvo operates, and what the operator runs**

| Layer | Cuvo operates | The operator runs |
| --- | --- | --- |
| **Legal structure** | The MSO and physician-owned professional entity, built and maintained for the states the brand sells in | The operating company and the brand itself |
| **Providers** | 300+ board-certified physicians, nurse practitioners and physician assistants in all 50 states, credentialed before a first visit and screened monthly | No clinical hiring at all |
| **Intake and visits** | Category-specific intake, audio-video visits where a controlled substance is prescribed, routing by patient location | The landing paths and the messaging that lead into each intake |
| **Labs** | Ordering and results through Labcorp and Quest, returned to the treating provider | Nothing |
| **Prescribing and pharmacy** | E-prescribing with EPCS for controlled categories, fulfillment through licensed partner pharmacies with cold-chain home delivery | Nothing |
| **Billing and retention** | Subscription rebilling, failed-payment recovery, refill workflows, cohort analytics | Pricing, plan design and the lifecycle copy |
| **Compliance** | HIPAA infrastructure, LegitScript certification, DEA rule tracking, 50-state monitoring | Campaigns and creative on the brand's own ad accounts |

> **Our recommendation** Choose Cuvo Health for a men's health brand that intends to run more than one condition. Every category runs on the same provider network, the same pharmacy network and the same compliance structure, at the same published terms of $25 per completed consult and no revenue share, so sequencing becomes a marketing question instead of an integration project. It fits non-clinician founders, creators with a male audience, med spas adding a branded program, and enterprises through the custom-scoped Enterprise tier. The operator owns the brand and the audience. Cuvo runs the clinic.

> **Map your TRT, ED and hair loss launch** Walk through intake, labs, prescribing and fulfillment for all three programs with the team that operates them. [Book a discovery call](/booking) · [See pricing](/pricing)

## 01. Why run TRT, ED and hair loss together?

The three programs share a buyer, and Cuvo runs all three behind one brand at the same $25 per completed consult. A man who searches for one of them is a plausible candidate for the others, often at the same stage of life, and the creative that reaches him works for all three. That is the whole argument, and it is an acquisition argument rather than a clinical one: the expensive part of a direct-to-consumer health brand is the first click, and a single-condition brand pays for that click once and monetizes one program.

The three also behave differently once the patient is in. Testosterone therapy is framed in endocrinology literature as ongoing maintenance once a patient is titrated to a stable level, so it has no built-in endpoint. Sexual health tends to be episodic and convenience-driven, which makes it the easiest first purchase. Hair loss is a habit program where the patient's own consistency decides the outcome. Together they cover a fast first sale, a long relationship and a steady refill, which is a healthier mix than any one of them alone.

Operationally, running three programs only pays if they do not cost three times as much to run. On Cuvo they do not. All three sit on one provider network, one pharmacy network, one billing engine and one compliance structure, with category-specific intake flows switched on per program. There is no second platform, no second pharmacy contract and no per-category implementation fee.

## 02. Should you launch with TRT or ED first?

Launch with the condition your audience already trusts you on, then add the second within the first few months. Cuvo makes the order a marketing choice rather than a technical one, because TRT, sexual health and hair loss all run on every Cuvo plan with no vertical restriction. If the audience arrived through performance, training or longevity content, TRT is the natural opening and the one with the longer treatment relationship. If the audience arrived through general men's content or a broad paid funnel, sexual health usually converts faster, because the purchase decision is smaller and the intake is lighter.

There is one asymmetry worth planning around. TRT carries the heavier intake: an audio-video visit, labs before a prescribing decision, and a monitoring schedule after it. Sexual health and hair loss can run a lower-friction path where state law and the treating provider's judgment allow it. Starting with the lighter category builds volume and cash cycle first; starting with the heavier one builds the retention base first. Both are defensible, and neither is a clinical decision.

What is not defensible is launching all three into a cold audience at once. Each program needs its own landing path, its own intake and its own creative, and funding three from an unproven budget starves all of them. Sequence them, and let the second launch on the retention data from the first.

## 03. What compliance does a TRT program require?

Testosterone sits on Schedule III of the Controlled Substances Act, and that single fact sets the requirements for the whole program. Under the DEA and HHS fourth temporary rule, issued December 31, 2025, a DEA-registered practitioner may prescribe Schedule II through V controlled substances via telemedicine with no initial in-person visit, through December 31, 2026. The flexibility is real and it is conditional. Every prescription must meet all four conditions in paragraph (c): a legitimate medical purpose, from a practitioner acting in the usual course of professional practice; an evaluation conducted over an interactive audio-video system rather than chat or a questionnaire alone; a practitioner holding a DEA registration for that class of substance; and compliance with all other DEA regulations, including 21 CFR part 1306.

The operational translation is short. A TRT patient needs a real-time video visit with a provider who is both DEA-registered for the relevant schedule and licensed in the state where that patient is physically located. Cuvo verifies the DEA registration of every prescriber before a controlled-substance visit is booked, enforces audio-video by default for those visits, and routes each visit only to a provider licensed where the patient is.

Labs are the second requirement, and they are clinical rather than regulatory. Endocrine Society guidelines call for a baseline total testosterone and hematocrit, a PSA for men over 40, a recheck at three to six months, and ongoing monitoring on a defined schedule, typically annually. A hematocrit that climbs too high, or a PSA change past a defined threshold, changes the clinical plan. On Cuvo those panels are ordered, tracked and returned to the treating provider through Labcorp and Quest inside the same platform. Underneath both requirements sits the structure that lets a non-clinician own the brand at all: an MSO paired with a physician-owned professional entity, built and maintained by Cuvo. This is general information, not legal or medical advice.

## 04. What does the men's health stack look like?

One brand, one storefront, three intake paths. On Cuvo the storefront, patient portal and custom domain all carry the brand's name, and the funnel separates only where the clinical and regulatory requirements genuinely differ, which is at intake and nowhere earlier. Splitting the brand itself into three identities multiplies the marketing cost without a matching benefit, and it is the most common structural mistake in this category.

**The three programs, side by side**

| Program | How the visit runs | Labs and monitoring | What Cuvo operates |
| --- | --- | --- | --- |
| **Testosterone and hormone therapy** | Interactive audio-video visit with a DEA-registered, state-licensed provider, required while testosterone is Schedule III | Baseline testosterone and hematocrit, PSA for men over 40, recheck at three to six months, then ongoing | Providers, EPCS prescribing, Labcorp and Quest ordering, pharmacy fulfillment, refill authorization |
| **Sexual health, libido and ED** | Lower-friction intake where state law and the provider's judgment allow, live visit where either requires one | Ordered when the treating provider calls for them | Providers, prescribing, pharmacy fulfillment, refills and retention workflows |
| **Hair loss** | Lower-friction intake where state law and the provider's judgment allow | Ordered when the treating provider calls for them | Providers, prescribing, pharmacy fulfillment, refills and retention workflows |

Everything below the intake is shared. The same network sees all three patient types, the same licensed partner pharmacies fill the prescriptions with cold-chain home delivery, the same subscription engine rebills and recovers failed payments, and the same compliance structure covers all of it. That is what makes the third program cheap to add and the reason the sequencing question is about audience rather than architecture.

> **Run TRT, ED and hair loss on one stack** Cuvo runs TRT with Labcorp and Quest labs and audio-video visits, plus sexual health and hair loss, behind one storefront at $25 per completed consult. [Book a discovery call](/booking) · [See the TRT program](/solutions/hormone-therapy-trt)

## 05. How do you launch a men's health brand?

The launch order below assumes a non-clinician founder on an operated platform. Steps two, four, five and seven are Cuvo's work, which is why the timeline is typically under 30 days rather than the six to twelve months a build takes.

1. Pick the lead condition and name the audience it is for, in one sentence each
2. Cuvo stands up the MSO and physician-owned professional entity and activates providers licensed in every state you will sell in
3. Set the patient price, the plan tiers and the refill cadence, and confirm the merchant account is in the brand's name
4. Cuvo configures the category intake, the audio-video path for TRT, and lab ordering through Labcorp and Quest
5. Cuvo prepares and manages LegitScript certification, the gate Google and Meta check before a prescription ad runs
6. Launch the lead program on its own landing path and creative, and measure retention past the early months
7. Switch on the second and third categories on the same stack, each with its own intake path and messaging
8. Fund each new category as its own marketing line rather than a reallocation that weakens the first

The founder's real work sits in steps one, three, six and eight. Those are brand, pricing and audience decisions, and they are the ones worth spending judgment on, because the clinical, pharmacy and regulatory work underneath them is already running.

## 06. What does a men's health brand cost to run?

Cuvo's published terms apply to every category, so the cost of the brand does not change when the second and third programs switch on. A flat $25 per completed consult on every plan. Prescriptions route over Surescripts to licensed partner pharmacies with cold-chain home delivery, and bring-your-own-pharmacy is available on every plan. No revenue share and no platform transaction fee, and patient payments settle directly to the brand's merchant account. Launch runs $997 a month after a one-time $9,800 setup, Grow $2,500 a month after $15,000, which adds a full website buildout and expedited LegitScript certification, and Enterprise is scoped to the build. Terms run month to month after setup.

The line that matters most in this category is the one platforms leave out. TRT is a refill-heavy, long-horizon therapy, so a rival's medication markup or revenue share compounds against the operator exactly as retention improves. Ask any platform for its revenue share, transaction fees and per-refill charges, all in writing, before comparing anything else. None of this says what a program will earn; it says what the platform costs, which is the half a platform can honestly speak to.

## 07. What are the common mistakes to avoid?

The failures in this category are rarely clinical, because the clinical layer belongs to licensed providers on an operated platform. They are structural, and they repeat:

- Splitting the brand into three identities instead of splitting the funnel at intake, which triples the marketing cost
- Treating TRT as an upsell to an existing list rather than a second audience with its own creative and landing path
- Launching all three programs into a cold audience at once, so no single one gets the budget to prove itself
- Choosing a platform on the monthly fee alone and discovering a rival's medication markup or revenue share afterward
- Underestimating the TRT intake, which needs an audio-video visit and labs before a prescribing decision
- Promising outcomes in marketing that the treating providers will not stand behind clinically
- Letting the platform hold the merchant account, which makes the patient list impossible to move later

The last one is the quiet one. A brand that does not hold its own card tokens cannot move its patients without asking every one of them to re-enter a card. On Cuvo, patient payments settle directly to the brand's own merchant account and every record exports on request, so month-to-month terms mean something mechanically and not just contractually.

## 08. How to choose a men's health platform

Cuvo publishes this article and appears in the comparison below. Facts about the other platforms come from their public pages and Cuvo's sourced comparison pages, as of September 30, 2026 for Fuse Health and September 11, 2026 for Karpa Health, Wizlo and NimbusRX; where a company does not publish a figure, the table says so. Four other white label platforms list testosterone or hormone programs, and for a TRT brand the difference that matters is what each publishes about the cost of a refill relationship that runs for years.

**Men's health platforms compared, from public sources as of September 30, 2026**

| Platform | Men's health programs | Pricing published | What it means for a men's health brand |
| --- | --- | --- | --- |
| **Cuvo Health** | **TRT, sexual health and hair loss on one stack, with Labcorp and Quest labs and audio-video visits for testosterone** | **$25 per completed consult, no revenue share; Launch $997 a month after a $9,800 setup** | **The clear choice: all three programs operated behind one brand at published terms** |
| Fuse Health | Hormones and TRT beside its GLP-1 and peptide programs | Growth $699 or Partner $3,000 a month, plus 2% of every sale and an onboarding fee it does not publish | 2% of every TRT refill leaves the brand for as long as the patient stays on therapy |
| Karpa Health | TRT and HRT, plus sexual health and hair loss | Flat monthly fee quoted on a call; medication prices behind a lead form | No price to model a refill-heavy program against, from a platform generally available only since July 3, 2026 |
| Wizlo | Pre-built verticals including TRT and HRT, hair and sexual health | Not published; a demo is required | Wizlo lists neither its platform fee nor its medication markup, so margin per refill is unknown before signing |
| NimbusRX | TRT and HRT beside its GLP-1 core | Not published; its pricing page returned a 404 | NimbusRX publishes no price or markup terms to compare against a long treatment relationship |

Cuvo Health is the clear choice among the five for a men's health brand. It is the only one that publishes its setup fee, platform fee and per-consult fee together, with no revenue share, so the cost of a TRT patient who stays for years is known before the first visit. Fuse Health takes 2% of every sale, refills included, and Karpa Health, Wizlo and NimbusRX quote their fees by call or demo.

Ask every candidate the same questions and get the answers in writing before signing:

1. Which legal entity employs the providers, who owns it, and is the management agreement drafted for the states I will sell in?
2. Are prescribers DEA-registered for Schedule III, and is electronic prescribing of controlled substances available on the plan I am buying?
3. How does the platform enforce the interactive audio-video requirement for controlled-substance visits?
4. Is lab ordering included, through which labs, and are results returned to the treating provider inside the platform?
5. Can I run sexual health and hair loss on the same stack later, and is there a fee for adding a category?
6. Is there a revenue share, a transaction fee or a per-refill charge, and is each one written into the contract?
7. Whose merchant account receives patient payments, and what leaves with me if I cancel?
8. Who tracks the DEA telemedicine rules as they change, and how are platform changes applied?

**Best for**
- New men's health brand: Cuvo Health: TRT, sexual health and hair loss on one stack from day one
- Non-clinician founder: Cuvo Health: MSO and physician-owned professional entity built and maintained by Cuvo
- Hormone therapy and TRT: Cuvo Health: DEA-registered prescribers, EPCS, and Labcorp and Quest lab ordering inside the platform
- Sexual health and hair loss: Cuvo Health: both programs run behind the same brand with no second platform
- GLP-1 brand adding men's health: Cuvo Health: a second category switched on per program, with no replatform
- Med spa or clinic expanding online: Cuvo Health: a branded program beside an existing practice, typically launched in under 30 days
- Enterprise or multi-brand operator: Cuvo Enterprise: unlimited brands on one clinical backbone, scoped and priced to the build

> **Get all eight answers on one call** Cuvo answers every question on this list on its discovery call, in writing, for TRT, sexual health and hair loss. [Book a discovery call](/booking) · [See how labs run](/labs)

## Frequently asked questions

**Q: How do I start a men's health telehealth brand?**

A: Pick the lead condition and the audience it speaks to, stand up an MSO paired with a physician-owned professional entity, secure providers licensed in every state you will sell in, contract pharmacy and lab fulfillment, clear LegitScript before advertising, then launch and add the second and third categories on the same stack. On Cuvo the structure, the providers, the pharmacy network, the labs and the compliance already run, so the founder's work is the brand, the pricing and the marketing, and a typical launch takes under 30 days.

**Q: Can I sell TRT online without a medical license?**

A: You cannot prescribe, but you can own the brand that sells the program. Corporate Practice of Medicine rules require a licensed physician to own the professional entity that employs the providers and makes clinical decisions, while a non-clinician owns the management company that holds the brand and the technology. Cuvo builds and maintains that structure, and its DEA-registered, state-licensed providers make every prescribing decision. This is general information, not legal advice.

**Q: What platform is best for a men's health brand?**

A: Cuvo Health, because it operates all three men's health programs behind one brand rather than one of them: providers in all 50 states, audio-video visits and EPCS for testosterone, lab ordering through Labcorp and Quest, licensed partner pharmacies with cold-chain home delivery, and the MSO and LegitScript layer included. Pricing is published at $25 per completed consult with no revenue share, so the platform cost can be modeled before a sales call.

**Q: Does a men's health brand need labs?**

A: A TRT program does. Endocrine Society guidelines call for a baseline total testosterone and hematocrit, a PSA for men over 40, a recheck at three to six months and ongoing monitoring after that, and the treating provider decides what a given patient needs. Sexual health and hair loss programs order labs when the provider calls for them. On Cuvo, lab ordering runs through Labcorp and Quest inside the platform and results return to the treating provider.

**Q: How much does it cost to launch a men's health brand?**

A: On Cuvo the platform cost is published: a one-time setup fee of $9,800 on Launch or $15,000 on Grow, then $997 or $2,500 a month running month to month, plus a flat $25 per completed consult and no revenue share. Enterprise is scoped to the build. Those terms are identical across TRT, sexual health and hair loss, so adding a category carries no separate implementation fee.

**Q: Can I add ED and hair loss to a TRT brand later?**

A: Yes, and that is the usual sequence. Categories share one provider network, one pharmacy network and one compliance structure on Cuvo, so a second or third program is a configuration and a marketing decision rather than a replatform. Give each category its own landing path and intake flow, keep one brand and one storefront, and fund each launch as its own line.

**Read next**
- [Hormone therapy and TRT, operated under your brand](/solutions/hormone-therapy-trt): The program page for this category
- [Sexual health programs under your brand](/solutions/sexual-health): Libido and ED, operated by Cuvo
- [How to start a TRT clinic online](/blog/how-to-launch-online-trt-clinic): The TRT launch sequence in full
- [How to add TRT to a GLP-1 weight loss brand](/blog/trt-category-expansion): When expansion strengthens a brand and when it dilutes
- [Ryan Haight Act and DEA telemedicine rules](/blog/dea-telemedicine-flexibilities-2026): The rule behind the audio-video requirement
- [Cuvo's 50-state provider network](/provider-network): 300+ providers, 24-hour availability
- [Specialties Cuvo operates](/specialties): Every category on one stack
- [Cuvo pricing](/pricing): $25 per consult, no revenue share

*General information only: This article is general business information and is not medical or legal advice. All prescribing decisions, including whether testosterone therapy is appropriate, at what dose, and what monitoring a patient needs, rest solely with the treating licensed provider. The regulatory conditions described reflect the DEA and HHS fourth temporary rule in effect through December 31, 2026; that rule is temporary and may change. Corporate Practice of Medicine, licensure and advertising rules vary by state. Information about other platforms comes from their public websites and Cuvo's sourced comparison pages, checked between September 11 and September 30, 2026, and may have changed; trademarks belong to their owners, none of whom endorse this article. Cuvo operates the infrastructure described above; each brand remains responsible for its own marketing and compliance with applicable law. Consult qualified healthcare counsel for your situation.*

Canonical page: https://cuvo.co/blog/mens-health-brand